Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

WestVac Biopharma Receives FDA Approval for COVID-19 Protein Vaccines Targeting XBB Variants

December 18, 2024
CompanyDrug

CARSgen Therapeutics Initiates Phase II Study for CT041 in Advanced Gastric Cancer

December 18, 2024
CompanyDeals

National Vaccine & Serum Institute Partners with Corning Life Sciences to Foster Innovation

December 18, 2024
CompanyDrug

CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment

December 18, 2024
CompanyMedical Device

Grand Pharmaceutical’s Novasight Hybrid System Receives Marketing Approval in China

December 18, 2024
CompanyDeals

HitGen Inc. Enters Research Agreement with ARase Therapeutics to Discover Oncology Inhibitors

December 18, 2024
CompanyDeals

BeiGene and The Max Foundation Collaborate to Expand Access to Brukinsa for CLL Patients

January 6, 2025
CompanyDrug

Huadong Medicine’s HDM1002 Receives NMPA Approval for Type 2 Diabetes Clinical Trial

December 18, 2024
CompanyDrug

Everest Medicines Completes Patient Enrollment in Etrasimod Phase III UC Trial

December 18, 2024
CompanyLegal / IP

HuidaGene Secures US Patent for High-Efficiency Cas12Max DNA Editing System

December 18, 2024
CompanyDrug

Jiangsu Hengrui’s SHR0302 Secures Clinical Trial Approval for GVHD Treatment

December 18, 2024
CompanyDrug

Sanofi’s VaxigripTetra Expands Influenza Vaccine Access to All Ages in China

December 18, 2024
1 2 … 7 8 9 10 11 … 18 19
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up